|  |  |  |  |  | Baseline study characteristics | ||
---|---|---|---|---|---|---|---|---|
Author (Y) (Total patients) | BMI studied (kg/m2) | Non-survivor/total | BMI | Age | Gender | Comorbid illnesses | Severity of acute illness | Other |
Studies of sepsis, severe sepsis, and septic shock | ||||||||
Sakr [31] (2008) (n = 431) | Underweight (<18.5) | NR/17c | NR | NR | NR | NR | SAPS II | NR |
Normal (18.5–24.9) | NR/179c | |||||||
Overweight (25–29.9) | NR/148c | |||||||
Obese (30–39.9) | NR/76c | |||||||
Very obese (>40) | NR/11c | |||||||
Wurzinger [15] (2010) (n = 301) | Underweight (<18.5) | 3/15 | Yesd | Yes | Yes | COPD, HTN, DM, CRI, HO, heart disease | SAPS IId | Admission year, origin of sepsis |
Normal (18.5–24.9) | 28/125 | |||||||
Overweight (25–29.9) | 15/95 | |||||||
Obese (30–39.9) | 4/66 | |||||||
Adamzik [32] (2011) (n = 125) | Continuous BMIa | NR | Yes | Yes | Yes | Hemofiltration/dialysis | SAPS II, SOFA score | IL-6d, aquaporin 5 genotyped, CRP, serum aldosterone, plasma angiotensin II, procalcitonin |
Arabi [17] (2013) (n = 2882) | Underweight (<18.5)b | 121/196 | Yes | Yes | Yes | ID, HF, COPD, DM, Elective surgery | APACHE II | Type and source of bacterial infection, type of sepsis interventions |
Normal (18.5–24.9) | 580/1020 | |||||||
Overweight (25–29.9)b | 444/816 | |||||||
Obese (30–39.9) | 349/680 | |||||||
Morbidly obese (>40) | 76/170 | |||||||
Wacharasint [16] (2013) (n = 730) | Continuous BMIa | NR | Yesd | NR | Yes | DM | APACHE IId | Lung infection, fungal infection |
Sakr [33] (2015) (n = 2696) | Underweight (<18.5) | NR | Yes | Yes | Yes | Comorbiditiese | SAPS II, SOFA score | Type and source of admission, need for mechanical ventilation or renal replacement therapy at ICU admission, type of hospital, ICU specialty, total number of ICU patients in 2011, number of staffed ICU beds, gross national income of country |
Normal (18.5–24.9) | NR | |||||||
Overweight (25–29.9) | NR | |||||||
Obese (30–39.9) | NR | |||||||
Very obese (>40) | NR |